Actively Recruiting
Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic Gastrectomy
Led by Gangnam Severance Hospital · Updated on 2025-02-25
134
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to determine whether Ropivacaine-Poloxamer 407 hydrogel provides non-inferior pain control compared to TAP block for patients undergoing minimally invasive gastrectomy. The results will guide postoperative pain management practices and enhance recovery protocols for gastric cancer surgery.
CONDITIONS
Official Title
Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic Gastrectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a histologically confirmed diagnosis of gastric adenocarcinoma prior to surgery.
- Patients who have undergone a complete surgical resection (R0 resection).
- Patients with an ASA (American Society of Anesthesiologists) score of 3 or below.
- Patients aged 20 years or older.
- Patients who have undergone laparoscopic or robotic gastrectomy
You will not qualify if you...
- Patients under 19 years of age.
- Presence of ascites or peritoneal metastasis.
- Patients who have undergone preoperative chemotherapy or radiotherapy.
- Diagnosis of malignancies other than gastric cancer.
- Uncontrolled diabetes, autoimmune diseases, hypertrophic scars, or keloid history affecting wound healing.
- History of allergy or adverse reactions to Ropivacaine or other local anesthetics.
- Pregnant women.
- Patients with preoperative chronic pain conditions, including CRPS.
- Patients with long-term preoperative use of opioid analgesics.
- Patients with psychiatric disorders likely to interfere with study participation.
- Patients with severe liver disease, renal disease, or arrhythmia.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gangnam Severance Hospital
Seoul, South Korea
Actively Recruiting
Research Team
I
In Gyu Kwon
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here